[We must] avoid placing AI at the centre and then working backwards to find a problem. Instead, we should take a problem-centric approach, identifying real-world challenges…
In Conversation
Our goal is to work together with the broader community to help end the HIV epidemic for everyone, everywhere
I feel that CAR-T cells are just the beginning of cell and gene therapy and foresee massive expansion in the next few years for which collaboration…
There has been a big change in the last few years within Novartis, where patient engagement is now very present across all our cross-functional teams
As a majority family owned group, Merck is also the oldest pharmaceutical company in the world and known throughout the market for its long-term vision. How…
The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth through acquisition in this extremely…
DAIICHI SANKYO in Germany, Austria and Switzerland DAIICHI SANKYO wants to be a Global Pharma Innovator with Germany at the center of this process on the…
Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in emerging markets, due to the increased prevalence of…
You joined Cegedim in summer 2006 eleven months before its merger with Dendrite in 2007 that created the world leader in pharmaceutical CRM. How would you…
The acquisition of Jerini has to be one of the biggest milestones for Shire Deutschland in its recent history. How have the synergies developed between the…
You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back…
Roche, once a true pharmaceutical company, is now recognized by its capacity to create a unique business model that allowed to become the world’s largest biotech…
